Latest Posts
About This Stock
More About This Stock
Read
Read
Read
September Summary: Largest Psychedelic Drug Stocks Dropped 14%
Article By:
Lorimer Wilson
Sunday, October 1, 2023 1:48 PM EDT
Seelos Therapeutics' market capitalization dropped below $50M with the recent dramatic decline in its share price and, as such, is no longer part of the Psychedelic Drug Stocks Index. The remaining members on average dropped 4% last week.
Psychedelic Drug Stocks Dragged Down By 83% Collapse In SEEL Stock Price
Article By:
Lorimer Wilson
Sunday, September 24, 2023 5:37 PM EDT
With the 82.6% collapse of Seelos Therapeutics (SEEL) last week, our Psychedelic Drug Stocks Index comprised of 6 psychedelic-compound-based research & development stocks declined by 13.0%, on average, and are now down 5.2% YTD.
4 Of The 6 Largest Psychedelic Compound-Based R & D Stocks Had A Good Week
Article By:
Lorimer Wilson
Sunday, September 17, 2023 12:01 AM EDT
4 of the 6 psychedelic-compound-based research & development stocks in our Psychedelic Drug Stocks Index were up in price last week versus only 1 the previous week. The Index was up 2.4% for the week and up 9.0% YTD.